NDA is a world leading drug development consultancy with a dedicated team of over 150 consultants supported by an expert network and a specialist Advisory Board.
|Type||Public / Private|
- High-Stakes Meeting Preparations
- HTA (Health Technology Assessment)
Understanding and managing the quality and potential risks of existing and new pharmaceutical products has never been more important than it is today. Ensuring this is done in an efficient and cost effective way, supported by the right expertise, process and systems, is critical to the survival of a drug on the market. The introduction of the new Pharmacovigilance Legislation in 2012 has made this even more paramount forcing greater focus on risk management and monitoring.
NDA has indepth expertise and experience of pharmacovigilance (PV) and managing risk for products already out on the market. We understand how a new drug needs to be tracked and monitored throughout its life, the data you now need to gather and store, the measurement and checks that will be undertaken to ensure its safety, and then how to deal with any potential concerns that may arise.